Peer Review History: Procalcitonin as a Biomarker and Risk Stratification Tool in COVID-19 Patients

Editor(s):

(1) Dr. Emmanouil (Manolis) Magiorkinis, General Hospital for Chest Diseases “Sotiria”, Greece.

(2) Dr. Masahiro Hasegawa, Mie University Graduate School of Medicine, Japan.

Reviewers:

(1) Hasanain Abdulhameed Odhar, Al-Zahrawi University College, Iraq.

(2) Pedro Pereira Tenório, Federal University of the São Francisco Valley, Brazil.

(3) Ajit kumar Shrivastava, HNGU, India.

(4) Mohamed Mousa Abd El-Mawgod, Al-Azhar University, Egypt.

Additional Reviewers:

(1) Agenor Gomes dos Santos-Neto, Tiradentes University, Brazil.

(2) Anju Kaushal, New Zealand.

(3) Selvi Radhakrishnan, Sri Ramachandra Institute of Higher Education and Research (SRIHER) Deemed University, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.87/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Hasanain Abdulhameed Odhar, Iraq) | File 1 | NA


Stage 2 | Peer review report_2 (Pedro Pereira Tenório, Brazil) | File 1 | NA


Stage 2 | Peer review report_3 (Ajit kumar Shrivastava, India) | File 1 | File 2


Stage 2 | Peer review report_4 (Mohamed Mousa Abd El-Mawgod, Egypt) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Posted in Review History.